HEADER LYASE 08-AUG-09 3IM0 TITLE CRYSTAL STRUCTURE OF CHLORELLA VIRUS VAL-1 SOAKED IN 200MM D- TITLE 2 GLUCURONIC ACID, 10% PEG-3350, AND 200MM GLYCINE-NAOH (PH 10.0) COMPND MOL_ID: 1; COMPND 2 MOLECULE: VAL-1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: C-TERMINAL DOMAIN, UNP RESIDUES 106-349; COMPND 5 SYNONYM: ALGINATE LYASE VAL-1; COMPND 6 EC: 4.2.2.3; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CHLORELLA VIRUS; SOURCE 3 ORGANISM_TAXID: 31555; SOURCE 4 STRAIN: CVK-2; SOURCE 5 GENE: VAL-1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET21B KEYWDS ALGINATE LYASE, POLYSACCHARIDE LYASE FAMILY 14, CHLORELLA VIRUS, KEYWDS 2 LYASE EXPDTA X-RAY DIFFRACTION AUTHOR K.OGURA,M.YAMASAKI,T.HASHIDUME,T.YAMADA,B.MIKAMI,W.HASHIMOTO,K.MURATA REVDAT 5 01-NOV-23 3IM0 1 HETSYN REVDAT 4 29-JUL-20 3IM0 1 COMPND REMARK SEQADV HETNAM REVDAT 4 2 1 SITE REVDAT 3 13-JUL-11 3IM0 1 VERSN REVDAT 2 22-DEC-09 3IM0 1 JRNL REVDAT 1 20-OCT-09 3IM0 0 JRNL AUTH K.OGURA,M.YAMASAKI,T.YAMADA,B.MIKAMI,W.HASHIMOTO,K.MURATA JRNL TITL CRYSTAL STRUCTURE OF FAMILY 14 POLYSACCHARIDE LYASE WITH JRNL TITL 2 PH-DEPENDENT MODES OF ACTION JRNL REF J.BIOL.CHEM. V. 284 35572 2009 JRNL REFN ISSN 0021-9258 JRNL PMID 19846561 JRNL DOI 10.1074/JBC.M109.068056 REMARK 2 REMARK 2 RESOLUTION. 1.66 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.66 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.0 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.163 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.163 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.216 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1711 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 32576 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.160 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 31335 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1901 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 12 REMARK 3 SOLVENT ATOMS : 453 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 2363.5 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 14 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 9879 REMARK 3 NUMBER OF RESTRAINTS : 8643 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 ANGLE DISTANCES (A) : 0.025 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.030 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.050 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.061 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.009 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.059 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3IM0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-AUG-09. REMARK 100 THE DEPOSITION ID IS D_1000054578. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-JUN-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL38B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : FIXED EXIT SI 111 DOUBLE CRYSTAL REMARK 200 MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU JUPITER 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34464 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.660 REMARK 200 RESOLUTION RANGE LOW (A) : 26.320 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 200 DATA REDUNDANCY : 5.400 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 74.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.66 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.72 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.5 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : 0.14400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 16.50 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 3GNE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% PEG 3350, 0.2M AMMONIUM FORMATE, REMARK 280 0.1M HEPES-NAOH PH7.0, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.20100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 50.35250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.56050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 50.35250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.20100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.56050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 1 REMARK 465 LEU A 245 REMARK 465 GLU A 246 REMARK 465 HIS A 247 REMARK 465 HIS A 248 REMARK 465 HIS A 249 REMARK 465 HIS A 250 REMARK 465 HIS A 251 REMARK 465 HIS A 252 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 116 NE - CZ - NH2 ANGL. DEV. = -4.3 DEGREES REMARK 500 TYR A 189 CA - CB - CG ANGL. DEV. = 11.9 DEGREES REMARK 500 TYR A 243 CB - CG - CD1 ANGL. DEV. = -3.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 27 -128.49 53.73 REMARK 500 ALA A 88 -129.40 54.51 REMARK 500 HIS A 93 -77.91 -104.82 REMARK 500 ALA A 103 43.15 -166.76 REMARK 500 ASN A 158 45.02 39.02 REMARK 500 ARG A 201 29.34 91.82 REMARK 500 ASN A 218 96.38 -161.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 SINCE O1 OF BDP IS MISSING IN THIS ENTRY, ALTERNATIVELY IT MAY BE REMARK 600 GCU(ALPHA-D-GLUCOPYRANURONIC ACID). REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 BDP A 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3GNE RELATED DB: PDB REMARK 900 LIGAND-FREE VAL-1 REMARK 900 RELATED ID: 3A0N RELATED DB: PDB REMARK 900 D-GLUCURONIC ACID-BOUND VAL-1 AT PH 7.0 DBREF 3IM0 A 1 244 UNP Q9DTZ2 Q9DTZ2_9PHYC 106 349 SEQADV 3IM0 LEU A 245 UNP Q9DTZ2 EXPRESSION TAG SEQADV 3IM0 GLU A 246 UNP Q9DTZ2 EXPRESSION TAG SEQADV 3IM0 HIS A 247 UNP Q9DTZ2 EXPRESSION TAG SEQADV 3IM0 HIS A 248 UNP Q9DTZ2 EXPRESSION TAG SEQADV 3IM0 HIS A 249 UNP Q9DTZ2 EXPRESSION TAG SEQADV 3IM0 HIS A 250 UNP Q9DTZ2 EXPRESSION TAG SEQADV 3IM0 HIS A 251 UNP Q9DTZ2 EXPRESSION TAG SEQADV 3IM0 HIS A 252 UNP Q9DTZ2 EXPRESSION TAG SEQRES 1 A 252 THR ASN VAL ILE SER THR LEU ASP LEU ASN LEU LEU THR SEQRES 2 A 252 LYS GLY GLY GLY SER TRP ASN VAL ASP GLY VAL ASN MET SEQRES 3 A 252 LYS LYS SER ALA VAL THR THR PHE ASP GLY LYS ARG VAL SEQRES 4 A 252 VAL LYS ALA VAL TYR ASP LYS ASN SER GLY THR SER ALA SEQRES 5 A 252 ASN PRO GLY VAL GLY GLY PHE SER PHE SER ALA VAL PRO SEQRES 6 A 252 ASP GLY LEU ASN LYS ASN ALA ILE THR PHE ALA TRP GLU SEQRES 7 A 252 VAL PHE TYR PRO LYS GLY PHE ASP PHE ALA ARG GLY GLY SEQRES 8 A 252 LYS HIS GLY GLY THR PHE ILE GLY HIS GLY ALA ALA SER SEQRES 9 A 252 GLY TYR GLN HIS SER LYS THR GLY ALA SER ASN ARG ILE SEQRES 10 A 252 MET TRP GLN GLU LYS GLY GLY VAL ILE ASP TYR ILE TYR SEQRES 11 A 252 PRO PRO SER ASP LEU LYS GLN LYS ILE PRO GLY LEU ASP SEQRES 12 A 252 PRO GLU GLY HIS GLY ILE GLY PHE PHE GLN ASP ASP PHE SEQRES 13 A 252 LYS ASN ALA LEU LYS TYR ASP VAL TRP ASN ARG ILE GLU SEQRES 14 A 252 ILE GLY THR LYS MET ASN THR PHE LYS ASN GLY ILE PRO SEQRES 15 A 252 GLN LEU ASP GLY GLU SER TYR VAL ILE VAL ASN GLY LYS SEQRES 16 A 252 LYS GLU VAL LEU LYS ARG ILE ASN TRP SER ARG SER PRO SEQRES 17 A 252 ASP LEU LEU ILE SER ARG PHE ASP TRP ASN THR PHE PHE SEQRES 18 A 252 GLY GLY PRO LEU PRO SER PRO LYS ASN GLN VAL ALA TYR SEQRES 19 A 252 PHE THR ASN PHE GLN MET LYS LYS TYR GLU LEU GLU HIS SEQRES 20 A 252 HIS HIS HIS HIS HIS HET BDP A 301 12 HETNAM BDP BETA-D-GLUCOPYRANURONIC ACID HETSYN BDP BETA-D-GLUCURONIC ACID; D-GLUCURONIC ACID; GLUCURONIC HETSYN 2 BDP ACID FORMUL 2 BDP C6 H10 O7 FORMUL 3 HOH *453(H2 O) HELIX 1 1 ASP A 8 GLY A 15 5 8 HELIX 2 2 GLY A 16 TRP A 19 5 4 HELIX 3 3 GLU A 121 GLY A 123 5 3 SHEET 1 A 4 VAL A 3 THR A 6 0 SHEET 2 A 4 GLN A 231 LYS A 241 -1 O MET A 240 N SER A 5 SHEET 3 A 4 LYS A 37 TYR A 44 -1 N TYR A 44 O GLN A 231 SHEET 4 A 4 ALA A 30 PHE A 34 -1 N ALA A 30 O LYS A 41 SHEET 1 B 6 VAL A 3 THR A 6 0 SHEET 2 B 6 GLN A 231 LYS A 241 -1 O MET A 240 N SER A 5 SHEET 3 B 6 ALA A 72 PHE A 80 -1 N THR A 74 O LYS A 241 SHEET 4 B 6 ASN A 166 LYS A 173 -1 O ILE A 168 N TRP A 77 SHEET 5 B 6 GLY A 186 VAL A 192 -1 O TYR A 189 N GLY A 171 SHEET 6 B 6 LYS A 195 ILE A 202 -1 O LEU A 199 N SER A 188 SHEET 1 C 7 VAL A 21 ASN A 25 0 SHEET 2 C 7 PHE A 59 ALA A 63 -1 O SER A 62 N ASP A 22 SHEET 3 C 7 ILE A 212 PHE A 221 -1 O TRP A 217 N PHE A 61 SHEET 4 C 7 GLY A 91 GLY A 99 -1 N GLY A 95 O ASP A 216 SHEET 5 C 7 GLY A 112 TRP A 119 -1 O ALA A 113 N ILE A 98 SHEET 6 C 7 VAL A 125 TYR A 130 -1 O TYR A 128 N ARG A 116 SHEET 7 C 7 ILE A 149 PHE A 151 -1 O ILE A 149 N ILE A 129 SHEET 1 D 2 PHE A 177 LYS A 178 0 SHEET 2 D 2 ILE A 181 PRO A 182 -1 O ILE A 181 N LYS A 178 CISPEP 1 GLY A 222 GLY A 223 0 -6.92 CISPEP 2 GLY A 223 PRO A 224 0 -2.47 CRYST1 40.402 71.121 100.705 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024751 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014061 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009930 0.00000